皮层反应动态的纵向变化与对治疗耐药抑郁症的脑下垂体垂体的深度大脑刺激
bioRxiv : the preprint server for biology
|December 11, 2025
概括
抑郁症的深度大脑刺激 (DBS) 显示,随着时间的推移,大脑信号的速度和强度得到了改善. 白质完整性预测了这些变化,为治疗优化提供了新的生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
- 神经调节是一种神经调节.
背景情况:
- 耐治疗抑郁症缺乏客观的恢复生物标志物.
- 脑下环皮层 (SCC) 的深度大脑刺激 (DBS) 显示出有希望的结果.
- 了解SCC-DBS电路动态是至关重要的.
研究的目的:
- 在SCC-DBS期间调查刺激唤起的潜能 (SEP) 的纵向变化.
- 为了确定反映SCC驱动的皮质通信的生物标志物.
- 为了将SEP动态与临床结果和白质完整性相关联.
主要方法:
- 10名接受SCC-DBS治疗的患者的高密度EEG记录在4周和24周.
- 来自SCC信号的SEP的源定位.
- 分析SEP延迟和规模的分析.
- 与临床结果的相关性和中环膜的微分异型 (FA).
主要成果:
- 皮层反应显示,随着时间的推移,慢性刺激的延迟时间降低,幅度增加.
- 观察到更快,更强的皮质电信号传递.
- 较高的基线中环 FA 预测了更大的 SEP 延迟加速.
- SEP的时间动态反映了电路的参与.
结论:
- 时间SEP动态是SCC-DBS的机械生物标志物的候选者.
- 这些生物标志物反映了神经调节过程中电路参与的演变.
- 这些发现支持对抑郁症的DBS进行生理指导的优化.
相关概念视频
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...


